Click on a company to learn more about their products or services.
Biomedical / Life Sciences / Medical Device
CyroMend, Inc. (CMI)
Epinex Diagnostics, Inc.
Medical Device Innovations (MDI)
NanoCellect Biomedical, Inc.
Ridge Diagnostics, Inc.
Z Medical Visualization Technologies
Software / Telecommunications / IT
BUMP Network, Inc.
Everyone Counts, Inc.
Global Village Concerns (GVC)
Precision Information (PI)
StereoVision Imaging, Inc.
The Language Express, Inc.
Analog Analytics is the largest provider of coupons, deal certificates and Bigger Better Deal™ solutions for local online publishers, broadcasters and advertisers. Analog Analytics’ massively scalable software platform delivers an interactive coupon and deal solution and offers important value-added services to help publishers and broadcasters launch, analyze and optimize deals, as well as source and distribute deals on Analog’s nationwide syndicated network. Its technology platform is utilized by more than 850 U.S. publishers and tens of thousands of advertisers worldwide, including; Advance Internet, Entertainment.com, Wick, LANG, MediaNews Group, Journal Register, McClatchy, Freedom Interactive, Entercom Communications, NBC TV, Local.com, Thomson Yellow Pages UK, New York Daily News, Newsday, RSVP and many more.
Antengo is reinventing classified listings for mobile from the ground up. By defining real-time classifieds, Antengo delivers a new marketplace that’s consumable on-the-go. Listings have 140 characters, GPS coordinates and enable secure, anonymous instant messaging from device-to-device. Antengo allows people to buy and sell tickets outside a venue, locate a specific item at a farmer’s market, or find a nearby plumber. Users can also connect around any community exchange, like a lost camera, finding a roommate at college, or setting up a carpool from the airport.
Assure Controls, Inc.
Assure Controls is a product development and marketing company with specialized measurement expertise for industrial biotechnology and environmental water applications. Its mission is to assure that water is safe for its intended use via assessment technologies that reduce the time, cost and complexity of water quality testing.
The Barc Communication Channel, Barc’s social networking and communication technology, allows users to chat with others who are browsing the same Website or Web page, viewing the same video or TV channel, or accessing the same WiFi network. Barc currently has two products in development; Barc Consumer and Barc Pro. Barc Consumer enables people to live chat with others browsing the same Website. Barc Pro provides owners of Websites with live group chats on every page in a cost effective manner.
BUMP Network, Inc.
The BUMP Network SAAS enterprise level data, membership management, and registration software provides advanced data management of consumers and enables enterprise clients to monetize their customers and offer them valuable benefits. BUMP has signed several significant high margin revenue producing contracts and is deep in contract discussions to secure additional contracts for this product, including large malls, conference companies, medical companies, sports companies and media groups.
CryoMend Inc. (CMI)
CMI has licensed the exclusive worldwide rights to CryoMedix LLC’s patented technology for generating very cold temperatures for the treatment of hypertension (HTN). They will obtain regulatory/marketing approval for its medical equipment (console and disposable catheters) for the treatment of HTN in the US, Europe and select international markets and sell its products to healthcare organizations throughout those areas. An early proof-of-concept animal study has been completed to verify the ability of the technology to lower blood pressure by freezing the blood vessels leading to the kidneys (blocks nerve signals).
Deal Current is a customizable daily deal (Groupon-like) software platform that entrepreneurs, media companies and online communities can use to launch a group buying deal program. The software is fully functional.
DermTech is a molecular diagnostics company preparing to commercialize MelDTect™, a novel non-invasive diagnostic assay for melanoma detection. The company will provide the test under a CLIA/CAP certified molecular testing lab. The company’s technology utilizes a custom tape strip to harvest cells from the surface of melanocytic lesions (moles) and a molecular laboratory developed assay that identifies RNA expression consistent with the presence of melanoma. In a series of studies on over 450 prospectively collected samples, the assay has demonstrated sensitivities exceeding 98% and a specificities exceeding 80%, yielding negative predictive values that exceed 99.5%. This compares much more favorably to existing clinical methods that have sensitivities of 80-90% with specificities of 10-30%. The company is seeking a $10M Series B to complete the commercial validation of its assay, achieve the necessary laboratory accreditation and begin commercial launch.
Diomics is a nanobioscience company focused on the development of Diomat® technology
for a range of life science, aerospace and specialty products. Diomat® is a novel class of nano-composite material. Today, Diomics is focused on life sciences, specifically forensics, biospecimen collection and integrated DNA analysis and profiling solutions. Diomics’ flagship product is X-Swab™. The X-Swab™ is a unique bio-specimen collection device based on Diomics? Diomat® technology. This versatile and easy-to-use product replaces the highly inefficient cotton swab, enabling immediate DNA forensics at the crime scene and genetic testing in the doctor?s office or at a patient?s bedside. Unlike cotton swabs that contaminate and damage the cells of the target collection material, the unique properties of the X-Swab™ not only collect more material, it safely manages and stores the specimen. The X-Swab™ allows for rapid DNA analysis as the XSwab?s™ collection head, made of Diomat® technology, will almost entirely dissolve away, leaving the target material behind for analysis and DNA profiling.
ecoATM is pioneering a new solution to an old problem which involves motivating people to participate in electronic recycling by creating financial incentives. ecoATM is the only company developing an automated machine to administer trade-in and electronic recycling programs for retailers and wireless carrier stores.
EcoDog developed hardware and software tools that enable homeowners to easily and affordably take control of energy consumption to lower their utility bills while contributing to overall reduction in demand for electricity. EcoDog’s FIDO Home Energy Watchdog System is an easy-to-use energy residential energy monitoring systems that shows users exactly how and where they are consuming electricity in real-time with room-by-room detail so they can readily identify “energy hogs” in the home.
Eolas Therapeutics, Inc.
Eolas Therapeutics is a therapeutic development company committed to treating the diseases of addiction. Their lead program is a first-in-class compound to treat nicotine addiction. Their compound, an orexin-1 receptor antagonist, is the first to directly address the brain circuitry of addiction rather than the drug signaling pathway. This target strategy can lead to a much safer and more effective therapy in the $2.5 billion smoking cessation market and has also been shown to be effective for cocaine and other drug addictions. Moreover, the team has a track record of bringing products from concept to market. In February 2013 their lead program was awarded the NIH Blueprint Neurotherapeutics Network grant to fund its program through completion of Phase I clinical trials. The company is seeking a $3M investment to accelerate their product to Phase II clinical trials.
Epinex Diagnostics, Inc.
Epinex Diagnostics is developing a revolutionary test for monthly diabetes monitoring (G1A™ test). Epinex provides more accurate and time sensitive data for large populations of diabetics. Its proprietary platform for rapid tests uses existing immunoassay and biosensor technologies to create unique quantitative diagnostic tests for the point-of-care (POC) and over-the-counter (OTC) markets.
EuMederis is focused on becoming a leader in the design and development of “Best in Class Peptide Therapeutics”, with improved compliance and efficacy due to non-invasive administration and prolonged duration of action. Peptides (mini-proteins) perform numerous critical roles throughout the body, e.g. governing appetite, metabolism, growth, pain, etc. Their principal shortcomings as pharmaceuticals include their short duration of effect and need for repeated self-injection (e.g. Byetta®). Peptides protected by the EuMederis proprietary modification (EuPort™) avoid these shortcomings, essentially de-risking peptide targets. EuPort™ is based on a novel, non-obvious chemical modification which allows broad patent protection of our therapeutic products following an extremely rapid design process, starting from known active molecules. Although the potential therapeutic applications and patent protection are very broad, initial products are treatments for osteoporosis, post-surgical pain, diabetes/metabolic syndrome, and pulmonary hypertension (orphan disease)/asthma, where early stage development is underway.
Everyone Counts, Inc.
Everyone Counts is a post-revenue technology startup with a strong management team, satisfied customers, highly qualified prospects, and field-proven technology. The business is Information Technology solutions for conducting elections, particularly for serving remote and disabled voters. The solutions allow governments to significantly improve operational processes, increase the accuracy of those processes and save more than half the cost of providing elections. Elections are a fast-growing multi-billion-dollar market, hungry for technical improvement with only a few competitors providing inadequate solutions.
EyeSonix is a medical device company created with the purpose of developing a new method of treating open angle glaucoma using non-invasive ultrasound.
Finder Technologies has invented and patented a new technology designed to locate a wide range of objects using wireless Radio Directional Finding (RDF) methods, from cars and trucks to children and pets. Using the world’s smallest directional antenna system, the Auto-Finder consists of two small transceivers, an in-car windshield-mounted beacon and a hand-held pointer remote about the size of a standard automobile key fob.
Freedom Meditech is a private, growth?stage medical device company focused on the development and commercialization of first?to?market, noninvasive, ophthalmic medical devices for disease detection and management of diabetes. Company’s technology is based on the scientific rationale that glucose (a small molecule), which is the hallmark of diabetes when present or elevated in the blood, presents rapidly within the fluid and blood of the eye. Freedom Meditech’s mission is to transform the current standards for disease detection and diabetes management through the development and commercialization of innovative ophthalmic based technologies. The ClearPath DS?120 system, is a proprietary non?invasive ophthalmic diagnostic device designed to quickly detect elevated advanced glycosolated end products (“AGEs”), a well?established biomarker of diabetes and pre?diabetes. This non?invasive bio?photonic approach represents a potential superior alternative to conventional cumbersome diabetes diagnostic and screening.
Gamer Grub is a performance snack designed for multi-tasking. Gamer Grub combines great taste with a proprietary blend of essential vitamins and neurotransmitters to support mental performance. Gamer Grub currently has four flavors; Pizza, PB&J, BBQ and S’mores – packaged in convenient ‘Tear N’ Tilt’ snack packs. Advisory board members include COO from Nabisco, sales director from Kettle Chips and brand manager from Red Bull. Gamer Grub has been sold into over 3,000 stores including Frys Electronics, Best Buy and ToysRus.
GIRx has developed a novel, safe and effective way to treat diabetes and other metabolic diseases. GIRx drugs avoid unwanted and often dangerous side effects of other drugs because GIRx drugs act within the gastrointestinal tract and do not enter the blood steam thereby avoiding or minimizing systemic drug distribution. GIRx’s lead candidate is based on a re-purposing of an existing off-patent drug, potentially reducing development & clinical trial risks.
Global Village Concerns (GVC)
GVC is creating a fundamental shift in the way schools and non-profit organizations raise money, while increasing visibility and community support. GVC’s team of world-class branding experts assess your organizational needs, make suggestions, build your brand image through its B1self branding program, then take the necessary steps to legally protect your brand identity. B1self is about expressing yourself, as well as uniting your entire community around a common cause. Through the unique B1self branding program, they create a custom designed B1selfShop.com online store leveraging your new brand—similar to the way colleges and professional sports operate.
GFC has created and deployed a ground transportation booking platform which allows passengers to request and track service though SMS, Web and smartphone applications in markets nationwide through both operator-branded and GFC-branded tools. GFC’s industry-friendly growth strategy and Private Label products will allow GFC to scale faster with less resistance than competitors. The largest and most powerful fleet operators in major cities nationwide are actively looking for a mobile booking technology that will allow them to offer the latest technology to passengers in a way that strengthens their brand relationship with the passenger – GFC provides exactly that solution. By partnering with established fleet brands that already serve 2-3 million passengers daily, it will be able to grow traffic without spending millions to establish a national brand. GFC is already operating with 19 major fleets in 13 U.S. markets and processes about 30,000 orders per month.
Go-Go Dog Pals
Go-Go Dog Pals provides the world’s growing dog owner community with an innovative and technologically advanced toy. Go-Go Dog Pals utilizes advanced Remote Control (RF) technology, combined with a ruggedized, lightweight, durable and stable chassis. The “Pals” that accessorize the chassis’ come in the form of many different real and imaginary animals and corresponding accessories. From squirrels and rabbits to unicorns and dragons, the choices are virtually endless to accessorize your pal and entertain your dog. The vision of Go-Go Dog Pals is to become a pet lifestyle company, combining a fun and challenging exercise session for dogs with an enjoyable and convenient option for dog owners. From dog owners with limited time for exercising their dog, to high energy, athletic dogs looking for a workout challenge, Go-Go Dog Pals will be the product of choice.
Hadronex is a rapidly growing early stage company spanning two recession-resistant emerging markets: clean technology and water infrastructure. Integrating 21st century technologies, the SmartCover® product helps utilities prevent sewage spills, and provides an on-line wireless digital data and sensor network that gives water and sanitation utilities the ability to manage their systems more effectively and efficiently. The SmartCover® has won multiple awards, including the California Association of Sanitation Agencies (CASA) award for most innovative technology, CONNECT’s Most Innovative Product Finalist in Clean Technology, and the American Electronics Association Clean Technology finalist.
HealthyPrice is a new approach to healthcare, acting as an advocate for the patient and as a business partner for the physician. It creates a much needed marketplace connecting patients and physicians with an easy to use e-commerce website that offers healthcare services and procedures from high quality doctors at affordable prices. HealthyPrice serves as a business partner to the physician increasing revenues and enabling access to a new market segment.
Independa, Inc. provides integrated technologies and solutions that help caregivers help their loved ones live at home longer, safer, and more comfortably. Independa subscription services address today’s gap in integrated solutions to deliver Technology-enabled Independent Living. Independa provides greater safety, social connectivity and dignity for care receiver, greater peace of mind for their family caregivers, and all-round significant cost savings versus today’s alternatives, especially “healthcare” pricing models families face for institutionalized eldercare.
Inhibrx is a biotherapeutics discovery and development company, with an extensive, internally-developed pipeline. Active programs are focused on cancer, inflammatory and metabolic diseases. Inhibrx’s pipeline spans first-in-class to best-in-class therapeutics. Inhibrx’s programs are based on comprehensive target discovery and selection expertise coupled to creative implementation of proprietary antibody generation, selection, functional enhancement and optimization platforms. Inhbrix’s focus is from target and antibody discovery through pre-clinical development. Inhibrx seeks to license individual programs with pharmaceutical companies for clinical development and commercialization. Inhibrx offers flexible program licensing and acquisition structures, including a risk-sharing approach that lowers a partner’s costs through clinical proof of concept.
Innovega offers 3D, HD, IMAX experience in fashionable eyewear. Consumers can wear a 3D display “as eyewear,” offering either immersion or mobility, depending on the desired experience. Innovega’s novel approach delivers a large and immersive display, yet within the confines of fashionable eyewear. The wearer gains all the benefits of contact lenses – improved vision in real-world. Its system of stylish eyewear working with special purpose contact lenses enables experiences that range from Avatar 3D/ IMAX immersion to the viewing of one’s cell-phone as a large monitor. The contact lens comprises normal prescription optics (if vision correction is required) plus a sub-millimeter optic to focus on the near-eye display plus optical, bio-compatible “nano-filters” that ensure both the ambient and media are easily processed by the user’s visual system.
JET Surgical is a regenerative medicine company that is developing a novel and proprietary product that will both improve the safety and recovery time of corneal wound healing in laser vision correction, especially for older cataract patients receiving premium IOL’s. By combining a modified collagen-coated contact lens with a layer of live cultured skin cells, the JET Lens device acts as a postoperative tissue transplant “bandage” in PRK. This device promotes more rapid recovery (like a skin graft promotes wound healing), and thus may elevate JET Lens PRK to the preferred laser vision correction procedure, providing safety combined with rapid recovery. The device may also be used to treat other corneal epithelial diseases such as herpetic keratitis, traumatic corneal abrasions, hereditary corneal erosions, and diabetic neurotrophic ulcers. Currently, no corneal epithelial transplant therapy is commercially available in the USA or world-wide. The JET Lens may revitalize the laser vision correction field and accelerate market adoption of presbyopia correcting IOL’s. The company is seeking $2.5M to construct a Master Cell Bank, file for IDE and conduct a phase 1 clinical trial in the USA. An additional $15M is required for phase 2, phase 3 and BLA filing.
Jury Box is a proven, well-reviewed software program which allows users to digitally manage all aspects of the jury selection process. Its users can scrap the cumbersome but previously prevailing methods of depending on Post-it® Notes or patchwork, in-house solutions for jury selection organization. Jury Box is designed specifically for needs of trial lawyers and trial consultants and first went on sale in July 2011. The CEO of Jury Box, Inc., Adam Gordon, is also a Deputy District Attorney for San Diego County. Jury Box is redefining the way that jury selection occurs in trials of all sizes, and has been used by the prosecution teams for the last two Prosecutors of the Year in San Diego County. Jury Box is seeking Series A funding to support enhanced management, marketing and development efforts.
Karuna Pharmaceuticals is a single project clinical stage pharmaceuticals company with the goal of developing the first in a new class of anti-psychotic drugs. The anti-psychotic drug market is the largest category in all of pharmaceuticals with sales totaling over $23BB in 2011, despite the fact that all of the currently available drugs belong to a single pharmacological class and are associated with only partial efficacy and a host of severe side effects, including; induction of irreversible movement disorders, obesity and type II diabetes. The company is led by Dr. Jay Kranzler as CEO, one of San Diego’s most experienced life science entrepreneurs, with a 24 year track record of running biotechnology companies, most recently Cypress Bioscience, where he developed Savella®, currently sold by Forest Laboratories for treatment of fibromyalgia.
KJAYA Medical, LLC
KJAYA’s mission is to improve patient care through the storage and rapid access of diagnostic quality medical scans via Intelligent Visualization® anytime, anywhere over the Internet. The vision is to embody observable 3D anatomical structures and computer aided diagnosis as an inherent component of a diagnostic workflow. KJAYA is overcoming the challenges of managing medical scans, to deliver the next generation Cloud PACS 3D RIS solution that is faster, accurate and affordable.
Life Cube Inc.
Developed the world’s first all-in-one solution to emergency preparedness, response and recovery. The patented 5’ shipping container is air-droppable, fits in the bed of a pick-up truck and can be pre-positioned in critical disaster prone areas with little maintenance. The container unfolds to create the only integrated, raised, hard-surface floor in the rapid deployment shelter industry and contains all the necessary components for survival.
LiquidGrids empowers life science companies to listen, understand and strategically engage in online health dialogue. LiquidGrids provides real-time digital health intelligence that makes it possible to get the right message, to the right people, at the right time. Its software solution distills hundreds of millions of online health conversations into relevant, actionable information. Its proprietary algorithms evaluate social media activity related to a specific health topic, classify conversations according to themes, discover conversation patterns, measure sentiment and intent and identify sources of influence in every conversation.
LocationSmart™ is the spin out of the TechnoCom Location Platform™ business unit from TechnoCom Corporation. It is a cloud-based location and messaging service that brings instant nationwide location awareness to enterprise and consumer applications. It simplifies the process of accessing location for over 350M phones, including over 240M mobile devices deployed by AT&T, Sprint, T-Mobile and Verizon. TechnoCom Location Platform has been adopted for resale by AT&T as their Location Information Services, embraced by enterprise class systems integrators and deployed within 20 client applications with monthly recurring revenues of $40K and growing.
LONOCLOUD produces and provides a software deployment and management platform that enables easier and more sustainable development and deployment on existing and emerging cloud infrastructures. The platform will enable customers who build large-scale, complex software systems to utilize the unique advantages of cloud providers to accelerate application development and deployment, provide better management and maintenance strategies, and allow for secure, fault-tolerant, dynamic scaling based on real-time usage. Additionally, LONOCLOUD will support and enable applications that are impacted by regulatory compliance mandates (HIPAA, SARBOX, etc.).
LuminOre CopperTouch (LCT)
LCT was formed to revolutionize the healthcare industry’s ongoing battle against antibiotic, antiseptic resistant bacteria populating medical and other facilities. LCT has developed new and innovative products with copper antimicrobial surfaces. In response to the health crisis of Healthcare Associated Infections, LCT will begin making a variety of products, primarily for hospitals, including bed railings, door handles, grab bars, toilet seats and more.
Malama Composites develops and manufactures proprietary rigid polyurethane (PU) foams made from natural, bio-based polyols. The resulting high performance core materials are currently sold under the trade name AinaCor™. They enable manufacturers to produce a wide range of products that are stronger, lighter, cost competitive, far less toxic and more easily recycled than alternative, petroleum-based foams. In Hawaiian, Malama means “to care for and protect.” The root of our product name, Aina, means “of the earth.” These words serve as the foundation for our mission, vision and corporate values.
MD Revolution, Inc.
MD Revolution integrates genetics, metabolics, and traditional medicine to develop a personalized health plan with proven outcomes. Patients and employees self-track their progress using RevUp, MD Revolution’s proprietary software platform. The 2net system from Qualcomm Life enables RevUp to capture the patient’s health, nutrition and exercise data from mobile apps and health devices in a HIPAA compliant, cloud-based system. Over 90% of patients in our programs experience statistically significant reductions in damaging visceral fat and improvements in metabolism and fitness. RevUp offers employers and primary care physicians a platform to dramatically scale and sustain outcome-based personalized healthcare.
Medical Device Innovations (MDI)
MDI has developed a new technology for treatment of atrial fibrillation with the goal of bringing a simpler solution to the treatment of this serious condition, estimated to occur in over ten million people worldwide and increasing. MDI improves the lives of patients through innovation that simplifies a complex and time-consuming procedure.
Medipacs, Inc. is developing the first non-mechanical infusion pump using a proprietary, expandable polymer. The Medipacs pump is designed to be wearable, programmable and disposable to allow for greater accuracy, patient comfort and convenience at a lower cost.
In 2009, the semiconductor company Infineon Technology approached MetraLabs with the need of next generation automation technologies. MetraLabs designed solutions based on mobile robots autonomously monitoring contaminations, transporting reticles and handling wafers in semiconductor production plants. This decreases contaminations and costs, while increasing flexibility and speed. The market opportunity for these systems is roughly $680M per year. MetraLabs is expected to gross $92M in annual revenues by year five.
MicroPower Technologies developed the power efficient wireless camera technology, which can be worn or mounted anywhere with no wires. The MicroPower low power consumption technology requires 1/20th the power of competing technologies for the wireless IP video cameras. MicroPower wireless cameras can run on AA battery powered up to 1 year or can run indefinitely using solar.
NanoCellect Biomedical, Inc.
NanoCellect’s game changing technology offers unique solutions to barriers imposed by current state of the art flow cytometers. The company’s mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. NanoCellect utilizes microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells within a disposable chip. By using microfluidic technology integrating novel detection algorithms with on-chip sorting, the soon-to-be launched flow cytometry system developed by NanoCellect will avoid dangerous aerosols, reduce shear stress on cells, and bring flow cytometry to more laboratories. It will have many applications in biomedical research including but not limited to cancer research, circulating tumor cells, stem cells, immunology, microbiology, sequencing of homogenous cell populations and much more.
Nasseo, Inc. is a medical device company that has developed a next generation dental and orthopedic implant surface modification technology to accelerate patient healing and clinician productivity. Nasseo’s first product is the TiArray™ dental implant system that integrates our proprietary surface modification technology to strengthen the bone-to-implant bond at the molecular level which is favorable for people with poor bone healing (e.g. smokers, diabetics) and also results in better outcomes for the general population. Nasseo offers dentists cost-effective, high quality, faster loading, and easy-to-use implants that significantly improve productivity and enable more immediate loading of the implants. Nasseo’s proprietary implant surface modification technology is backed by $1.5M in grants and can be applied to a variety of materials (titanium, tantalum, polymers, PEEK, etc.) and applications (dental, spinal, trauma, joint, etc.). Nasseo has recently closed on a $520K seed financing round and is seeking a $3M+ Series A round by the summer of 2013 to increase manufacturing capability and to sell the TiArray™ system starting in early 2014 and is seeking strategic partners for the development of our platform technology in non-dental markets.
A healthcare technology and services company focused on reducing hospital readmission rates by filling gaps in patient care between hospital discharge and follow-up appointments. Based upon its proprietary platform, the company’s service integrates each patient’s discharge instructions into a Recovery Care Pathway that provides patients and their caregivers with daily, interactive and recovery support. The NudgeRx Recovery Guidance Engine™ (RGE) strictly follows instructions provided by the patient’s doctor and provides patients with a personalized Recovery Care Pathway ™ (RCP). Its services lower the risk of re-hospitalization, improve quality of care and lower overall health costs. The company started a pilot project to support the recovery of heart surgery patients in early Q3 2011 with Sharp Healthcare in San Diego.
Pacific Integrated Energy (PI Energy)
PI Energy has developed a technology platform to directly convert light energy using nano-photonic materials that enables new classes of commercializable devices across several markets.
Precision Information (PI)
PI has bootstrapped its business to build a high margin, niche B2B publishing company under the Educated Investor® brand name. The Educated Investor® team has closed deals creating a royalty revenue stream of over $5M (with base license fees averaging roughly $500K per year) by licensing its technology and content to major financial service firms such as Quicken®, TurboTax®, New York Life, Morningstar, Merrill Lynch and many more. The Educated Investor® team recently developed new software as a service to create online “Financial Fitness” competitions in the workplace. Over the past 2+ years, the company has engaged 300+ companies and nearly 25K employees to spend over 250K hours of online learning about money. The Educated Investor team has put plans in place to expand this SaaS based financial education delivery model to serve over 4M employees per year by 2016.
ProManPTO has developed, patented and introduced the first add-on Hydraulic Power-Take-Off (PTO) system for the All-Terrain Vehicle (ATV) and Utility Terrain Vehicle (UTV) market. Their “Green” system, along with an ever growing series of proprietary work implements, will transform the customer’s ATV or UTV from an expensive, underutilized vehicle into the most mobile and versatile property management or construction site tool.
Retail Inkjet Solutions
Retail Inkjet Solutions, Inc. has developed and currently markets a proprietary system designed specifically for refilling inkjet printer cartridges on-site at major retail, university and corporate locations. This unique solution provides the highest quality inkjet refills to consumers at more than 50 percent savings; while delivering the reliability, ease-of-use, throughput and upgradeability demanded by major retailers. The RIS InkCenter™ solution has placements today in major retail locations nationwide.
Ridge Diagnostics, Inc.
Ridge Diagnostics is a neurodiagnostic company developing and marketing a portfolio of blood-based tests for neuropsychiatric disorders. The initial product, a blood test for clinical depression or Major Depressive Disorder (MDD), is currently being marketed in the U.S. to psychiatrists, pain management physicians and select primary care providers in pilot markets and is receiving reimbursement from insurance companies. This novel approach promises to change the standard of care for a large unmet clinical need by providing objective diagnostic and antidepressant therapy monitoring tests for the over 20M individuals suffering with depression in the U.S. The MDDScoreTM measures 10 individual biological system markers and incorporates a proprietary algorithm. Ridge conducts testing services at its laboratory which operates under guidelines established by the Clinical Laboratory Improvement Amendments (CLIA).
ShowUhow is the developer and provider of the 360? Product Experience Solution, which enables manufacturers and retailers to improve product profitability and gather real time product usability analytics though the delivery of a series of on-demand, video-based Product Guides. These video Product Guides are distributed via smartphones, Web and social media for every stage of the customer purchase life cycle; pre-sale education, installation, feedback and repeat business through brand loyalty.
Stablcor Technology, Inc.
Solves thermal and mechanical problems in Printed Circuit Boards and IC Substrates. Its patented STABLCOR® product, (a carbon composite laminate), when embedded into a PCB allows electronics to pass beyond the thermo-mechanical limitations of today’s current materials and technologies. STABLCOR® began as a NASA invested project and has been successfully tested and used in the space and defense industries by prime contractors including Boeing, Raytheon and General Dynamics.
StereoVision Imaging, Inc.
3D imaging company focused on 3D product development technology for the government and industry. Through binoculars, the mobile, hand-held 3D facial recognition enhancement technology (FRT) enables covert surveillance and remote facial identification at extended ranges (currently up to 100 meters) outdoors under various environmental conditions. Technology (software) can also be applied and licensed to enhance exiting indoor security checkpoint operations.
Develops, manufactures and markets molecular imaging agents. The company is developing new applications for its technology in diagnostic imaging and therapy, and has launched several products for use in the preclinical drug discovery and research market. The company’s technology is based on proprietary acoustically active microspheres, which enable researchers to identify diseases at the molecular level using portable and cost-efficient ultrasound imaging technology. Targeson launched its first product line, Targestar™, in late 2005 and has recently launched its second generation of targeted ultrasound contrast agents, VisistarTM.
Tellus Technology, Inc.
A platform waste-to-renewables technology; Tellus Process. The process up cycles used tires, into commercially accepted commodities – IsoBlack™, oil, steel and gas. IsoBlack™ is the only recycled carbon black product that performs as well as its virgin counterpart in commercial rubber and plastics applications. It is an essential 20 billion pound per year ingredient in the global rubber and plastic markets.
Provides turnkey telemedicine platforms for healthcare providers that enable live medical-gradeTM video and audio from cell phones. telmedx helps reduce the cost of healthcare by enabling caregivers to remotely observe, diagnose and triage patients, and offer follow-up care, monitor drug compliance and other health statuses.
Ten8Tech is dedicated to delivering innovative SaaS offers that dramatically improve police department productivity. The CASE SERVICE increases productivity of patrol staff while enhancing police services for citizens. The CASE SERVICE enables agencies to off-load minor incident reports that currently occupy more than 20% of a patrol officer’s day. Citizens are directly transferred by 911 operators into the “virtual investigator service,” which promptly helps them complete a report. The initial 2012 launch of the patent pending CASE SERVICE offer will be followed by a stream of additional SaaS-based products.
TetraVue uses patent-pending laser and techniques to enable off-the-shelf digital imaging components (including CMOS imaging chips) to record 3D images with potential for cost reduction to consumers. TetraVue builds on concept already proven by government programs, adding patent-pending techniques that enable commercial use. Key areas are high resolution and automatic data processing. Company’s patent applications already filed. Preliminary experiments and design predict millimeter resolution and 30 Mpt/s speed in handheld device which matches criteria identified by NIST for ideal 3D measurement device.
The Language Express, Inc.
The Social Express™ is an engaging, interactive software application designed for children with autism, Asperger’s and ADHD. Their software teaches children how to think about and manage social situations through video modeling, thus enabling them to build social-emotional skills and develop the meaningful relationships they need to navigate life.
Transient Plasma Systems (TPS)
Develops and produces compact, ultra-short, high-voltage electrical pulse generators. The TPS proprietary platform technology involves delivering extremely short (nanoseconds), low-energy, intense electrical pulses. When applied to fuel-burning engines, these ultra-short pulses yield substantial improvements in fuel efficiency and performance (more than 20%).
Tricopian’s mission is to replace billions of household batteries consumed each year with a high-performance, low-cost and eco-friendly alternative. SaveME batteries are formulated using a unique technology that allows them to “refuel” them many times over. When the batteries are no longer useable, they can be easily and economically recycled unlike disposable batteries which end up in landfills.
Vaxiion Therapeutics is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Their current focus is the development of a programmable, and therefore intelligent, platform capable of delivering chemotherapeutic drugs directly to cancer cells, thereby improving efficacy while reducing the toxic side effects associated with current chemotherapy treatment regimes.
ViewBug is an online photo contest community providing an opportunity for photographers to share photos with chances to win prizes. ViewBug gives everyone an opportunity to be discovered. Unlike other photography competitions, ViewBug makes the photography contests fun and social by providing prizes by the best brands in the industry and including the most influential photographers as judges. Participants can also help judges select winners with a social media voting tool. A fast-growing company, ViewBug is based in San Diego with business development partners in Las Vegas and San Francisco.
Visionary is a privately held drug discovery company focused on innovative small molecule immunomodulator therapies. Visionary is currently developing first-in-class retinoic acid-related orphan nuclear receptor modulators and Selectin antagonists targeting Th17 cells. These cells are critical drivers of the pathophysiology of more than 70 different autoimmune diseases, such as Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Asthma, COPD and more. Together the market for these diseases represents over $200B in annual sales per year. Visionary’s management and scientific team have more than 120 years of combined drug discovery experience and have delivered more than 12 drugs into clinical trials or onto the market. Visionary has recently entered into a service-for-equity research collaboration worth up to $5,000,000 that substantially leverages investor capital. Visionary will out-license its programs preclinically to Big Pharma
Z Medical Visualization Technologies
Z Medical Visualization Technologies designs, patents and markets medical image processing technology and related devices to endoscopic or minimally invasive surgical (MIS) markets. The Z Medical Image Processor is a small dedicated computer system that receives live video streams from the surgical camera, applies image processing algorithms that remove distortion and improve image clarity and then transmits the enhanced image stream to standard display monitors in the operating room.